Physician profile
Israt Jahan
NPI 1447637129
$2,544.43
in general payments reported to CMS, 2019-2025
22 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $239 · 2021: $354 · 2022: $559 · 2023: $45.11 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $989 · Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.08 |
| Food and Beverage | $403.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,285.64 | 2025 | Percept PC Brainsense |
| Abbott Laboratories | $332.93 | 2022-2023 | Infinity |
| Neurocrine Biosciences, INC. | $229.92 | 2020-2022 | |
| Ucb, INC. | $97.05 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $70.23 | 2021 | |
| Mdd US Operations, LLC | $69.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $61.90 | 2025 | Iovera |
| Allergan, INC. | $52.54 | 2020-2021 | |
| Lilly USA, LLC | $42.41 | 2020-2022 | |
| Abbvie INC. | $40.04 | 2022 | |
| Kyowa Kirin, INC. | $38.70 | 2022-2023 | Nourianz |
| Amneal Pharmaceuticals LLC | $29.64 | 2020 | |
| Alexion Pharmaceuticals, INC. | $29.62 | 2022 | |
| Acorda Therapeutics, INC | $27.44 | 2022 | |
| Mallinckrodt Hospital Products INC. | $26.58 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $25.87 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $22.02 | 2021 | |
| Biogen, INC. | $18.08 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.81 | 2022 | |
| Emd Serono, INC. | $14.91 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.10 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Israt Jahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.